AEPCX
Price
$58.34
Change
+$0.18 (+0.31%)
Updated
Jun 6 closing price
Net Assets
133.45B
CIGCX
Price
$18.44
Change
+$0.01 (+0.05%)
Updated
Jun 6 closing price
Net Assets
264.87M
Interact to see
Advertisement

AEPCX vs CIGCX

Header iconAEPCX vs CIGCX Comparison
Open Charts AEPCX vs CIGCXBanner chart's image
American Funds EUPAC C
Price$58.34
Change+$0.18 (+0.31%)
VolumeN/A
Net Assets133.45B
Calamos International Growth C
Price$18.44
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets264.87M
AEPCX vs CIGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. CIGCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and CIGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. CIGCX (265M). AEPCX pays higher dividends than CIGCX: AEPCX (0.32) vs CIGCX (0.00). AEPCX was incepted earlier than CIGCX: AEPCX (24 years) vs CIGCX (20 years). CIGCX (2.15) is less costly to investors than AEPCX (1.59). CIGCX is a more actively managed with annual turnover of: 127.00 vs. AEPCX (30.00). AEPCX has a lower initial minimum investment than CIGCX: AEPCX (250) vs CIGCX (2500). AEPCX annual gain was more profitable for investors over the last year : 1.93 vs. CIGCX (1.43). AEPCX return over 5 years is better than : 14.63 vs. CIGCX (3.19).
AEPCXCIGCXAEPCX / CIGCX
Total Expense Ratio1.591.9582%
Annual Report Gross Expense Ratio1.592.1574%
Fund Existence24 years20 years-
Gain YTD12.90912.371104%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets133B265M50,189%
Annual Yield % from dividends0.320.00-
Returns for 1 year1.931.43135%
Returns for 3 years14.7415.3996%
Returns for 5 years14.633.19459%
Returns for 10 years21.4411.08193%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIO3.310.26
+8.52%
Orchestra BioMed Holdings
SES1.040.07
+6.97%
SES AI Corp
ENVB1.300.04
+3.17%
Enveric Biosciences Inc
TMDX139.053.46
+2.55%
TransMedics Group
REXR36.030.48
+1.35%
Rexford Industrial Realty